Full-Time

Senior Director

Manufacturing Operations, Gmp

Posted on 1/11/2024

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Compensation Overview

CA$202.6k - CA$253.2k/yr

+ Equity + Annual Bonus

Expert

Vancouver, BC, Canada

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Risk Management
Requirements
  • BS/MS/PhD in biological sciences, engineering or relevant scientific discipline
  • 12-15+ years of experience in manufacturing of biologics in a GMP setting
  • 6+ years of experience in a leadership role managing technical operations, process development, and/or GMP manufacturing operations
  • Outstanding technical acumen, operational understanding, and GMP compliance in building and managing the new GMP facility
  • Experience leading a site through quality audits and/or regulatory inspections
  • Experience with CMC regulatory filings
Responsibilities
  • Providing exceptional leadership to the organization, including hiring, mentoring, and developing staff
  • Serving as the senior manufacturing operations leader for the design, construction, and start-up of a new GMP Manufacturing facility for the production of antibody therapeutics
  • Working closely with site leadership and quality peers to develop and implement all GMP systems with an emphasis on paperless eSystems
  • Working closely with TechOps peers in process & analytical development to establish a paradigm for efficient process transfer and for SME technical support to manufacturing
  • Ensuring the schedules of the people, facility, equipment, materials, and documents are established and maintained to support the throughput of the facility
  • Identifying and mitigating risks in manufacturing operations that could negatively impact delivery of safe and effective therapies to patients
  • Providing senior leadership to ensure the facility and operation is prepared for all quality audits by AbCellera partners and regulatory inspections by global regulatory agencies and that any findings are addressed promptly
  • Reviewing and approving controlled master documents including standard operating procedures, batch records, material specifications, and validation protocols
  • Budgeting and planning including working closely with the Business Development team to support establishment of global partnerships for antibody discovery-through-GMP
Desired Qualifications
  • Strongly self-motivated and able to identify project needs and implement solutions
  • Passionate about building dynamic new teams and capabilities that accomplish important goals
  • Desire to innovate and push to do things differently
  • Enthusiastic about applying expertise in manufacturing operations
  • Outstanding communicator and teammate

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Vancouver, Canada

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • AbCellera's collaboration with AbbVie expands its oncology T-cell engager programs.
  • The partnership with Viking and ArrowMark aims to launch new biotech companies.
  • AbCellera's AI-driven discovery platform enhances precision and speed in drug development.

What critics are saying

  • Increased competition from genomic data leaders like Illumina may impact market share.
  • Strategic misalignments with PE partners could affect AbCellera's operational focus.
  • Rapid AI integration in biotech requires AbCellera to enhance its AI capabilities.

What makes AbCellera Biologics unique

  • AbCellera excels in rapid antibody discovery using a proprietary technology platform.
  • The company has strong partnerships with leading pharmaceutical firms like Eli Lilly.
  • AbCellera's focus on challenging targets sets it apart in the biopharmaceutical market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Paid Sick Leave

Flexible Work Hours

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 1%
Business Wire
May 9th, 2025
AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera presents positive preclinical data on ABCL575 at the 2025 SID Annual Meeting.

Montreal Gazette
Mar 25th, 2025
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera announces presentation of in vivo data on PSMA x CD3 T-Cell engagers at AACR 2025.

Stock Titan
Jan 13th, 2025
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbCellera (ABCL) has expanded its collaboration with AbbVie (ABBV) to develop novel T-cell engagers (TCE) in oncology, building upon their partnership from December 2022.

North Carolina Biotechnology Center
Sep 30th, 2024
Dualogics Sells Antibody Platform to Canadian Company | North Carolina Biotechnology Center

Durham-based Dualogics has sold its core technology for producing therapeutic antibodies to a Canadian biotechnology company.

Stock Titan
Jul 31st, 2024
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

AbCellera (Nasdaq: ABCL) has expanded its collaboration with Eli Lilly to develop antibody medicines for immunology, cardiovascular disease, and neuroscience programs.

INACTIVE